Bengaluru: Global pharma major, Lupin Limited, has announced the launch of its new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka, as part of the expansion of its diagnostics network.
“The new laboratory in Bengaluru is equipped with cutting-edge technologies and staffed by highly qualified clinical experts, enabling Lupin Diagnostics to deliver high-quality and reliable diagnostic services to patients and consumers across Bengaluru and neighboring cities,” the company stated in its release.
In addition to routine and specialized tests, the laboratory offers a comprehensive range of diagnostics services, including molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, haematology, histopathology, immunology, routine biochemistry, among others.
Read also: Lupin Gets CDSCO Panel Nod for Phase IV CT of pulmonary FDC drug
“Ensuring that quality diagnostics are accessible and affordable for everyone in India is at the core of our mission,� says Ravindra Kumar, CEO of Lupin Diagnostics.
“Accurate diagnosis is crucial for effective disease management, and we are committed to providing our patients with reliable, high-quality diagnostic services. With our cutting-edge technology and personalized smart reports, patients and doctors can gain valuable insights into health trends and make informed decisions about treatment options,� he added.
Read also: Lupin Diagnostics launches Regional Reference Laboratory in Indore
Lupin Diagnostics Limited is a wholly owned subsidiary of Lupin Limited. Founded in December 2021, the company is headquartered in Mumbai, India and provides comprehensive range of diagnostic services to doctors, patients, and consumers.
The company began its journey by establishing a state-of-the-art 45,000 sq. ft. National Reference Laboratory located in Navi Mumbai. Over 2,500 tests including routine and high-end tests are offered under Pathology (molecular diagnostics, cytology, microbiology, serology, hematology, histopathology, immunology, and routine biochemistry. Currently, the company’s network consists of 25 Labs, 410+ exclusive collection centers (LupiMitra), and over 1200 pick-up points.
GIPHY App Key not set. Please check settings